GCP
ELOS

GSA Capital Partners’s Syneron Medical Ltd ELOS Stock Holding History

GSA Capital Partners’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-22,952
Closed -$242K – 2128
2017
Q1 		$242K Buy
22,952
+400
+2% +$3.87K 0.01% 1490
2016
Q4 		$189K Buy
22,552
+1,654
+8% +$13K 0.01% 1609
2016
Q3 		$150K Sell
20,898
-9,400
-31% -$65.4K 0.01% 1653
2016
Q2 		$233K Sell
30,298
-41,340
-58% -$295K 0.01% 1509
2016
Q1 		$524K Sell
71,638
-29,297
-29% -$210K 0.03% 994
2015
Q4 		$778K Buy
100,935
+40,572
+67% +$309K 0.04% 882
2015
Q3 		$432K Buy
60,363
+18,151
+43% +$174K 0.02% 1204
2015
Q2 		$448K Buy
42,212
+23,412
+125% +$274K 0.02% 1412
2015
Q1 		$233K Buy
+18,800
New +$208K 0.01% 1850
2014
Q4 		– Sell
-14,900
Closed -$149K – 2035
2014
Q3 		$149K Buy
+14,900
New +$152K 0.01% 1582

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

GSA Capital Partners's ELOS Position: Q2 2017 in Review

GSA Capital Partners sold out of Syneron Medical Ltd (ELOS) in Q2 2017, closing a stake of 22,952 shares — an estimated $242K sold.

GSA Capital Partners first reported a position in ELOS in Q3 2014 and held it in 10 quarters. The position peaked at $778K in Q4 2015. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2017.

  • GSA Capital Partners reported no remaining Syneron Medical Ltd position as of Q2 2017 after selling out during the quarter.
  • GSA Capital Partners sold 22,952 Syneron Medical Ltd shares in Q2 2017, an estimated $242K.
  • GSA Capital Partners first reported a position in Syneron Medical Ltd in Q3 2014 and held it in 10 quarters.
  • GSA Capital Partners's Syneron Medical Ltd position peaked at $778K in Q4 2015.
  • 79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2017.

Based on GSA Capital Partners's 13F filing for Q2 2017, filed 11 Aug 2017.